AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimequick-M 1 Tablet

Prescription Icon
Prescription Required

Marketer

Cure Quick Pharmaceuticals

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimequick-M 1 Tablet

DiaBeta-Duo, a single tablet formulation, is classified as an anti-diabetic medication. This dual-action therapy is indicated for adult patients with type 2 diabetes mellitus, effectively managing glycemic control. DiaBeta-Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on individual response and blood glucose monitoring. Continued use, even with controlled blood sugar or feeling well, is crucial. Discontinuation without medical consultation risks elevated blood glucose, potentially leading to complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor; lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequently reported adverse effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to manage them. Consistent mealtimes and carrying a rapid-acting glucose source (e.g., sugary snacks or juice) are preventative measures. Alcohol consumption elevates hypoglycemia risk and should be minimized. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may also occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Glimequick-M 1 Tablet

Managing type 2 diabetes

Major Benefits of Glimequick-M 1 Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. One Glimequick-M tablet should be administered with a meal.

Common Side effects of Glimequick-M 1 Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimequick-M 1 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. One Glimequick-M tablet should be administered with a meal.

How Glimequick-M 1 Tablet works:

Glimequick-M, a single-tablet formulation, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness in peripheral tissues.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimequick-M 1 Tablet and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimequick-M 1 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any possible risks prior to prescribing this medication. Seek medical advice before use.

Breast feedingBreast feedingUNSAFE

Lactation and Glimequick-M 1 Tablet are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimequick-M 1 Tablet cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimequick-M 1 Tablet cautiously, potentially requiring a modified dosage. Consult a physician before use. A reduced initial dose is typically prescribed for those with mild to moderate liver disease; it's contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Glimequick-M 1 Tablet :

Should you forget to take a Glimequick-M 1 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimequick-M 1 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimequick-M 1 Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimequick-M 1 Tablet can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimequick-M 1 Tablet and seek immediate medical attention.
Glimequick-M 1 Tablet combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is unsuitable for type 1 diabetes.
Glimepiride (Glimequick-M) may cause common side effects such as low blood sugar, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glimepiride (Glimequick-M) use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental Vitamin B12 is recommended by some researchers.
Glimepiride (Glimequick-M) can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimepiride (Glimequick-M) with alcohol is unsafe. This combination can dangerously lower blood sugar, causing hypoglycemia, and may also increase the risk of lactic acidosis.
Glimequick-M 1 Tablet
48
MRP 58
17% off